nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—White blood cell count increased—Metformin—polycystic ovary syndrome	0.274	0.331	CcSEcCtD
Halofantrine—Rigors—Metformin—polycystic ovary syndrome	0.0674	0.0813	CcSEcCtD
Halofantrine—Abdominal distension—Metformin—polycystic ovary syndrome	0.0348	0.0419	CcSEcCtD
Halofantrine—Chills—Metformin—polycystic ovary syndrome	0.0248	0.0299	CcSEcCtD
Halofantrine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0223	0.0269	CcSEcCtD
Halofantrine—Malaise—Metformin—polycystic ovary syndrome	0.0217	0.0262	CcSEcCtD
Halofantrine—Palpitations—Metformin—polycystic ovary syndrome	0.0213	0.0256	CcSEcCtD
Halofantrine—Myalgia—Metformin—polycystic ovary syndrome	0.0205	0.0247	CcSEcCtD
Halofantrine—Chest pain—Metformin—polycystic ovary syndrome	0.0205	0.0247	CcSEcCtD
Halofantrine—Discomfort—Metformin—polycystic ovary syndrome	0.0202	0.0244	CcSEcCtD
Halofantrine—Anorexia—Metformin—polycystic ovary syndrome	0.0187	0.0226	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0179	0.0216	CcSEcCtD
Halofantrine—Paraesthesia—Metformin—polycystic ovary syndrome	0.0176	0.0213	CcSEcCtD
Halofantrine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0173	0.0209	CcSEcCtD
Halofantrine—Decreased appetite—Metformin—polycystic ovary syndrome	0.0171	0.0206	CcSEcCtD
Halofantrine—Fatigue—Metformin—polycystic ovary syndrome	0.0169	0.0204	CcSEcCtD
Halofantrine—Constipation—Metformin—polycystic ovary syndrome	0.0168	0.0203	CcSEcCtD
Halofantrine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0162	0.0195	CcSEcCtD
Halofantrine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0161	0.0194	CcSEcCtD
Halofantrine—Urticaria—Metformin—polycystic ovary syndrome	0.0156	0.0188	CcSEcCtD
Halofantrine—Abdominal pain—Metformin—polycystic ovary syndrome	0.0155	0.0187	CcSEcCtD
Halofantrine—Asthenia—Metformin—polycystic ovary syndrome	0.0141	0.017	CcSEcCtD
Halofantrine—Pruritus—Metformin—polycystic ovary syndrome	0.0139	0.0168	CcSEcCtD
Halofantrine—Diarrhoea—Metformin—polycystic ovary syndrome	0.0134	0.0162	CcSEcCtD
Halofantrine—Dizziness—Metformin—polycystic ovary syndrome	0.013	0.0157	CcSEcCtD
Halofantrine—Vomiting—Metformin—polycystic ovary syndrome	0.0125	0.0151	CcSEcCtD
Halofantrine—Rash—Metformin—polycystic ovary syndrome	0.0124	0.0149	CcSEcCtD
Halofantrine—Dermatitis—Metformin—polycystic ovary syndrome	0.0124	0.0149	CcSEcCtD
Halofantrine—Headache—Metformin—polycystic ovary syndrome	0.0123	0.0148	CcSEcCtD
Halofantrine—Nausea—Metformin—polycystic ovary syndrome	0.0117	0.0141	CcSEcCtD
Halofantrine—CYP3A4—urine—polycystic ovary syndrome	0.0054	0.146	CbGeAlD
Halofantrine—CYP2D6—urine—polycystic ovary syndrome	0.00531	0.143	CbGeAlD
Halofantrine—KCNH2—endometrium—polycystic ovary syndrome	0.00206	0.0556	CbGeAlD
Halofantrine—KCNH2—uterus—polycystic ovary syndrome	0.0019	0.0512	CbGeAlD
Halofantrine—CYP2C8—endometrium—polycystic ovary syndrome	0.00189	0.0508	CbGeAlD
Halofantrine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00186	0.0503	CbGeAlD
Halofantrine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00171	0.046	CbGeAlD
Halofantrine—KCNH2—adrenal gland—polycystic ovary syndrome	0.00167	0.0449	CbGeAlD
Halofantrine—KCNH2—female gonad—polycystic ovary syndrome	0.00155	0.0419	CbGeAlD
Halofantrine—KCNH2—vagina—polycystic ovary syndrome	0.00154	0.0416	CbGeAlD
Halofantrine—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00153	0.0414	CbGeAlD
Halofantrine—KCNH2—endocrine gland—polycystic ovary syndrome	0.00144	0.039	CbGeAlD
Halofantrine—CYP2C8—vagina—polycystic ovary syndrome	0.00141	0.0381	CbGeAlD
Halofantrine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00132	0.0356	CbGeAlD
Halofantrine—CYP3A5—female gonad—polycystic ovary syndrome	0.00128	0.0346	CbGeAlD
Halofantrine—CYP3A5—vagina—polycystic ovary syndrome	0.00127	0.0344	CbGeAlD
Halofantrine—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00119	0.0322	CbGeAlD
Halofantrine—CYP2D6—female gonad—polycystic ovary syndrome	0.000947	0.0255	CbGeAlD
Halofantrine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000895	0.0241	CbGeAlD
Halofantrine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000881	0.0238	CbGeAlD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.0008	0.00598	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00079	0.00591	CbGpPWpGaD
Halofantrine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000789	0.00591	CbGpPWpGaD
Halofantrine—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000773	0.00578	CbGpPWpGaD
Halofantrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000771	0.00577	CbGpPWpGaD
Halofantrine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000761	0.00569	CbGpPWpGaD
Halofantrine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000742	0.00555	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00074	0.00553	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000722	0.0054	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000722	0.0054	CbGpPWpGaD
Halofantrine—CYP2C8—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000719	0.00538	CbGpPWpGaD
Halofantrine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000718	0.00537	CbGpPWpGaD
Halofantrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—polycystic ovary syndrome	0.000712	0.00532	CbGpPWpGaD
Halofantrine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000708	0.0053	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000697	0.00522	CbGpPWpGaD
Halofantrine—KCNH2—Neuronal System—DLG4—polycystic ovary syndrome	0.000654	0.00489	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000648	0.00485	CbGpPWpGaD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000633	0.00474	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00063	0.00472	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000625	0.00468	CbGpPWpGaD
Halofantrine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000625	0.00467	CbGpPWpGaD
Halofantrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000621	0.00465	CbGpPWpGaD
Halofantrine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000613	0.00459	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000588	0.0044	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000582	0.00435	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00058	0.00434	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000563	0.00421	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000555	0.00415	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000546	0.00408	CbGpPWpGaD
Halofantrine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000535	0.004	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000527	0.00394	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000523	0.00391	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000521	0.0039	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000516	0.00386	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000514	0.00384	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000513	0.00384	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000512	0.00383	CbGpPWpGaD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00051	0.00382	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000509	0.00381	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000504	0.00377	CbGpPWpGaD
Halofantrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000504	0.00377	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000502	0.00376	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000485	0.00363	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000484	0.00362	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000483	0.00362	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000478	0.00357	CbGpPWpGaD
Halofantrine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000463	0.00347	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000456	0.00341	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000451	0.00338	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000448	0.00335	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000445	0.00333	CbGpPWpGaD
Halofantrine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000434	0.00324	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000424	0.00317	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00042	0.00314	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00042	0.00314	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000418	0.00313	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000414	0.0031	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000414	0.0031	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000414	0.00309	CbGpPWpGaD
Halofantrine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000413	0.00309	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000413	0.00309	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000408	0.00306	CbGpPWpGaD
Halofantrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000397	0.00297	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000383	0.00287	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000382	0.00286	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000382	0.00286	CbGpPWpGaD
Halofantrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00038	0.00285	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000378	0.00283	CbGpPWpGaD
Halofantrine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000376	0.00281	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00037	0.00277	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000365	0.00273	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000346	0.00259	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000345	0.00258	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000344	0.00258	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00034	0.00254	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000335	0.00251	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000334	0.0025	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000332	0.00248	CbGpPWpGaD
Halofantrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000329	0.00246	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000327	0.00245	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00032	0.0024	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000309	0.00231	CbGpPWpGaD
Halofantrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000308	0.00231	CbGpPWpGaD
Halofantrine—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000305	0.00228	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000304	0.00227	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000293	0.00219	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00029	0.00217	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000273	0.00205	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000273	0.00204	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000272	0.00203	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00027	0.00202	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00027	0.00202	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000269	0.00201	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000268	0.002	CbGpPWpGaD
Halofantrine—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000264	0.00197	CbGpPWpGaD
Halofantrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000249	0.00186	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000249	0.00186	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000249	0.00186	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000246	0.00184	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000242	0.00181	CbGpPWpGaD
Halofantrine—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00024	0.00179	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000239	0.00179	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	0.000235	0.00176	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000231	0.00173	CbGpPWpGaD
Halofantrine—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.00023	0.00172	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000226	0.00169	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000225	0.00168	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000225	0.00168	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000222	0.00166	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00022	0.00164	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000219	0.00164	CbGpPWpGaD
Halofantrine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000217	0.00162	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	0.000215	0.00161	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	0.000215	0.00161	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000213	0.00159	CbGpPWpGaD
Halofantrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000202	0.00151	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	0.0002	0.0015	CbGpPWpGaD
Halofantrine—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	0.0002	0.00149	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000196	0.00147	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000196	0.00147	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000196	0.00146	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000193	0.00145	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000183	0.00137	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000178	0.00133	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000177	0.00132	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000177	0.00132	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000176	0.00131	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000173	0.0013	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	0.00017	0.00127	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	0.00017	0.00127	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000165	0.00123	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000164	0.00123	CbGpPWpGaD
Halofantrine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000164	0.00123	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000164	0.00122	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000161	0.00121	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000156	0.00117	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000149	0.00111	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000144	0.00107	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000143	0.00107	CbGpPWpGaD
Halofantrine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000142	0.00106	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.00014	0.00105	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.00014	0.00105	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000135	0.00101	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000133	0.000993	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000129	0.000965	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000127	0.000954	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000127	0.000947	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000126	0.000945	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000117	0.000876	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000116	0.000865	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000116	0.000865	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000115	0.000864	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000115	0.00086	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000113	0.000844	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000111	0.00083	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.000821	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000109	0.000818	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000108	0.000811	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000107	0.000804	CbGpPWpGaD
Halofantrine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000107	0.000801	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000106	0.000792	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000103	0.000769	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000101	0.000753	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.0001	0.000748	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	9.78e-05	0.000731	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	9.74e-05	0.000729	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	9.47e-05	0.000708	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	9.44e-05	0.000706	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	9.39e-05	0.000703	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	9.14e-05	0.000683	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	9.14e-05	0.000683	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	9.02e-05	0.000675	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	9e-05	0.000674	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	8.91e-05	0.000667	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	8.71e-05	0.000652	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	8.44e-05	0.000631	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	8.41e-05	0.00063	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	8.28e-05	0.00062	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	8.21e-05	0.000614	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	8.13e-05	0.000609	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	8.03e-05	0.0006	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.81e-05	0.000585	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	7.77e-05	0.000581	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.77e-05	0.000581	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.72e-05	0.000577	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.66e-05	0.000573	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.66e-05	0.000573	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	7.29e-05	0.000545	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.26e-05	0.000543	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	7.17e-05	0.000537	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—TH—polycystic ovary syndrome	7.17e-05	0.000536	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	7.15e-05	0.000535	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	6.97e-05	0.000522	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	6.93e-05	0.000518	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.92e-05	0.000518	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	6.68e-05	0.0005	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	6.56e-05	0.00049	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	6.42e-05	0.00048	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	6.34e-05	0.000474	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	6.21e-05	0.000464	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.17e-05	0.000462	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	6.04e-05	0.000452	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	5.98e-05	0.000448	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	5.89e-05	0.000441	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.89e-05	0.00044	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	5.85e-05	0.000438	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.68e-05	0.000425	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	5.57e-05	0.000417	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.37e-05	0.000402	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	5.28e-05	0.000395	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.25e-05	0.000393	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5.1e-05	0.000381	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.08e-05	0.00038	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	5.07e-05	0.000379	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.96e-05	0.000371	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	4.93e-05	0.000369	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.83e-05	0.000361	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.68e-05	0.00035	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	4.66e-05	0.000349	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.58e-05	0.000342	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.53e-05	0.000339	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.37e-05	0.000327	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.27e-05	0.000319	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.19e-05	0.000314	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.16e-05	0.000311	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.14e-05	0.00031	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.99e-05	0.000299	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.96e-05	0.000297	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.94e-05	0.000295	CbGpPWpGaD
Halofantrine—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.92e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.91e-05	0.000293	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.85e-05	0.000288	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.76e-05	0.000281	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.5e-05	0.000262	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.46e-05	0.000259	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.41e-05	0.000255	CbGpPWpGaD
Halofantrine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.39e-05	0.000254	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.33e-05	0.000249	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.24e-05	0.000243	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.05e-05	0.000228	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.84e-05	0.000213	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.8e-05	0.00021	CbGpPWpGaD
Halofantrine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.79e-05	0.000208	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.72e-05	0.000204	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.59e-05	0.000194	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.46e-05	0.000184	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.29e-05	0.000171	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.86e-05	0.000139	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.83e-05	0.000137	CbGpPWpGaD
Halofantrine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.82e-05	0.000136	CbGpPWpGaD
